1-4 of 4
Donn Young, PhD
Close
Sort by
Journal Articles

The Addition of CT Scans to NCI-96 Chronic Lymphocytic Leukemia (CLL) Response Criteria Fails To Improve the Predictive Power of Complete Response (CR) and Partial Response (PR) as Assessed by Improvement in Progression-Free (PFS) and Overall Survival (OS) .

Kristie A. Blum, MD, Donn Young, PhD, Sarah Broering, Margaret S. Lucas, Thomas S. Lin, MD, PhD, Michael R. Grever, MD, John C. Byrd, MD
Journal: Blood
Blood (2006) 108 (11): 2833.
https://doi.org/10.1182/blood.V108.11.2833.2833
Published: 2006
Journal Articles

Excessive Neurotoxicity in a Phase II Trial of Combined Bortezomib and Rituximab in Patients with Relapsed/Refractory Mantle Cell (MCL) and Follicular (FL) Non-Hodgkin’s Lymphoma.

Kristie A. Blum, MD, Margaret S. Lucas, Jeffrey S. Johnston, PhD, James Dalton, PhD, Donn Young, PhD, Robert A. Baiocchi, MD, PhD, Thomas S. Lin, MD, PhD, Pierluigi Porcu, MD, John C. Byrd, MD
Journal: Blood
Blood (2006) 108 (11): 2768.
https://doi.org/10.1182/blood.V108.11.2768.2768
Published: 2006
Journal Articles

Novel Anti-CD37 Small Modular Immunopharmaceutical (SMIP) Induces B-Cell-Specific, Caspase-Independent Apoptosis in Human CLL Cells.

Xiaobin B. Zhao, MS, Sabyasachi Biswas, PhD, Andrew Mone, MD, PhD, Jeffrey Ledbetter, PhD, Martha Hayden Ledbetter, PhD, Laura Grosmaire, PhD, Erik Espling, PhD, Carolyn Cheney, Donn Young, PhD, Robert J. Lee, PhD, Natarajan Muthusamy, PhD, John C. Byrd, MD
Journal: Blood
Blood (2004) 104 (11): 2515.
https://doi.org/10.1182/blood.V104.11.2515.2515
Published: 2004
Journal Articles

A Phase II Study of the TNF-α Inhibitor Etanercept and Thrice Weekly Rituximab: Evidence of Clinical Activity in the Absence of del(17p13.1) Genomic Abnormalities.

Thomas S. Lin, MD, PhD, Nyla A. Heerema, PhD, Jennifer Swenor, Margaret S. Lucas, PA-C, Mollie E. Moran, CRNP, Carolyn M. Cheney, MS, David M. Lucas, PhD, Donn Young, PhD, Michael A. Caligiuri, MD, Michael R. Grever, MD, John C. Byrd, MD
Journal: Blood
Blood (2004) 104 (11): 3469.
https://doi.org/10.1182/blood.V104.11.3469.3469
Published: 2004